Zalifrelimab

Tax included
Zalifrelimab (AGEN1884) is a fully human IgG1 monoclonal antibody targeting CTLA-4 (CTLA-4). Zalifrelimab antagonizes the inhibitory checkpoints of immune cell activation regulated by CTLA-4 signaling.
MedChemExpress 
HY-P99514

Data sheet

Size
Multiple sizes
Reactivity
CTLA-4
Application
Cancer-programmed cell death
CAS
2148321-69-9